The prognostic value of S100A10 expression in cancer (Review)
- Authors:
- Normastuti Adhini Tantyo
- Azrina Saraswati Karyadi
- Siti Zulimas Rasman
- Marvelmario Reginald Gabriel Salim
- Astrella Devina
- Anton Sumarpo
-
Affiliations: Department of Biomedicine, Indonesia International Institute for Life Sciences, Jakarta Timur 13210, Indonesia, Department of Biochemistry, Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta Utara 14440, Indonesia - Published online on: November 23, 2018 https://doi.org/10.3892/ol.2018.9751
- Pages: 1417-1424
-
Copyright: © Tantyo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Kim SI, Sohn J, Koo JS, Park SH, Park HS and Park BW: Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Oncology. 79:324–330. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Novelli G, Ciccacci C, Borgiani P, Papaluca Amati M and Abadie E: Genetic tests and genomic biomarkers: Regulation, qualification and validation. Clin Cases Miner Bone Metab. 5:149–154. 2008.PubMed/NCBI | |
|
Jin H, Lee HC, Park SS, Jeong YS and Kim SY: Serum cancer biomarker discovery through analysis of gene expression data sets across multiple tumor and normal tissues. J Biomed Inform. 44:1076–1085. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ and Geczy CL: Functions of S100 proteins. Curr Mol Med. 13:24–57. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chazin WJ: Relating form and function of EF-hand calcium binding proteins. Acc Chem Res. 44:171–179. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Santamaria-Kisiel L and Shaw GS: Identification of regions responsible for the open conformation of S100A10 using chimaeric S100A11-S100A10 proteins. Biochem J. 434:37–48. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Svenningsson P and Greengard P: p11 (S100A10)-an inducible adaptor protein that modulates neuronal functions. Curr Opin Pharmacol. 7:27–32. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bissonnette L, Drissennek L, Antoine Y, Tiers L, Hirtz C, Lehmann S, Perrochia H, Bissonnette F, Kadoch IJ, Haouzi D and Hamamah S: Human S100A10 plays a crucial role in the acquisition of the endometrial receptivity phenotype. Cell Adhes Migr. 10:282–298. 2016. View Article : Google Scholar | |
|
Domínguez F, Garrido-Gómez T, López JA, Camafeita E, Quiñonero A, Pellicer A and Simón C: Proteomic analysis of the human receptive versus non-receptive endometrium using differential in-gel electrophoresis and MALDI-MS unveils stathmin 1 and annexin A2 as differentially regulated. Hum Reprod. 24:2607–2617. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
He KL, Deora AB, Xiong H, Ling Q, Weksler BB, Niesvizky R and Hajjar KA: Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem. 283:19192–19200. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
O'Connell PA, Madureira PA, Berman JN, Liwski RS and Waisman DM: Regulation of S100A10 by the PML-RAR-α oncoprotein. Blood. 117:4095–4105. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Phipps KD, Surette AP, O'Connell PA and Waisman DM: Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res. 71:6676–6683. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bharadwaj A, Bydoun M, Holloway R and Waisman D: Annexin A2 heterotetramer: Structure and function. Int J Mol Sci. 14:6259–6305. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Carpenter SL and Mathew P: Alpha2-antiplasmin and its deficiency: Fibrinolysis out of balance. Haemophilia. 14:1250–1254. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sitek B, Sipos B, Alkatout I, Poschmann G, Stephan C, Schulenborg T, Marcus K, Lüttges J, Dittert DD, Baretton G, et al: Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J Proteome Res. 8:1647–1656. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Swisher JF, Burton N, Bacot SM, Vogel SN and Feldman GM: Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood. 115:549–558. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Miles LA and Parmer RJ: S100A10: A complex inflammatory role. Blood. 116:1022–1024. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Huang B, Deora AB, He KL, Chen K, Sui G, Jacovina AT, Almeida D, Hong P, Burgman P and Hajjar KA: Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood. 118:2918–2929. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Duronio RJ and Xiong Y: Signaling pathways that control cell proliferation. Cold Spring Harb Perspect Biol. 5:a0089042013. View Article : Google Scholar : PubMed/NCBI | |
|
Madureira PA, O'Connell PA, Surette AP, Miller VA and Waisman DM: The biochemistry and regulation of S100A10: A multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol. 2012:3536872012. View Article : Google Scholar : PubMed/NCBI | |
|
Suzuki S and Tanigawara Y: Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells. Proteome Sci. 12:262014. View Article : Google Scholar : PubMed/NCBI | |
|
Shan X, Miao Y, Fan R, Qian H, Chen P, Liu H, Yan X, Li J and Zhou F: MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and inhibition of the Wnt pathway. Int J Mol Sci. 14:8556–8569. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Egeland M, Warner-Schmidt J, Greengard P and Svenningsson P: Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol Psychiatry. 67:1048–1056. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Ren H, Ren J, Yin T, Hu B, Xie S, Dai Y, Wu W, Xiao Z, Yang X and Xie D: The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma. Mediators Inflamm. 2013:6512072013. View Article : Google Scholar : PubMed/NCBI | |
|
Johnson H, Del Rosario AM, Bryson BD, Schroeder MA, Sarkaria JN and White FM: Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics. 11:1724–1740. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Riau AK, Setiawan M, Mehta JS, Ti SE, Tong L, Tan DT and Beuerman RW: S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue. Mol Vis. 17:2263–2271. 2011.PubMed/NCBI | |
|
Shang J, Zhang Z, Song W, Zhou B, Zhang Y, Li G and Qiu S: S100A10 as a novel biomarker in colorectal cancer. Tumour Biol. 34:3785–3790. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CY and Lin CF: Annexin A2: Its molecular regulation and cellular expression in cancer development. Dis Markers. 2014:3089762014. View Article : Google Scholar : PubMed/NCBI | |
|
Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell. 140:883–899. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Neurath MF and Finotto S: IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 22:83–89. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Dufour A and Overall CM: Missing the target: Matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci. 34:233–242. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Godier A and Hunt BJ: Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease. J Thromb Haemost. 11:26–34. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hajjar KA: The Biology of Annexin A2: From vascular fibrinolysis to innate immunity. Trans Am Clin Climatol Assoc. 126:144–155. 2015.PubMed/NCBI | |
|
Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013. View Article : Google Scholar : PubMed/NCBI | |
|
Huang D, Yang Y, Sun J, Dong X, Wang J, Liu H, Lu C, Chen X, Shao J and Yan J: Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia. Front Med. 11:410–422. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qian Y, Deng J, Xie H, Geng L, Zhou L, Wang Y, Yin S, Feng X and Zheng S: Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling. J Cancer Res Clin Oncol. 135:379–386. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Hou Y, Zhang J and Zhang L: The expressions and roles of S100A6 and S100A10 in gastric cancer. Biomed Res. 28:2131–2138. 2017. | |
|
O'Connell PA, Surette AP, Liwski RS, Svenningsson P and Waisman DM: S100A10 regulates plasminogen-dependent macrophage invasion. Blood. 116:1136–1146. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kaelin WG Jr and Ratcliffe PJ: Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell. 30:393–402. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y and Cao X: Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl). 94:509–522. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bhatia A and Kumar Y: Cellular and molecular mechanisms in cancer immune escape: A comprehensive review. Expert Rev Clin Immunol. 10:41–62. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Alvarez-Breckenridge CA, Wang QE and Yu J: TGF-β signaling and its targeting for glioma treatment. AM J Cancer Res. 5:945–955. 2015.PubMed/NCBI | |
|
Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL and Parsa AT: TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol. 12:7–13. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lindau D, Gielen P, Kroesen M, Wesseling P and Adema GJ: The immunosuppressive tumour network: Myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 138:105–115. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Terabe M and Berzofsky JA: The role of NKT cells in tumor immunity. Adv Cancer Res. 101:277–348. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Krock BL, Skuli N and Simon MC: Hypoxia-induced angiogenesis: Good and evil. Genes Cancer. 2:1117–1133. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Siemann DW: The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-vascular disrupting agents. Cancer Treat Rev. 37:63–74. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Luo M and Hajjar KA: Annexin A2 system in human biology: Cell surface and beyond. Semin Thromb Hemost. 39:338–346. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bydoun M and Waisman DM: On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: An enduring ambiguity. Future Oncol. 10:2469–2479. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Deryugina EI and Quigley JP: Cell surface remodeling by plasmin: A new function for an old enzyme. J Biomed Biotechnol. 2012:5642592012. View Article : Google Scholar : PubMed/NCBI | |
|
van Hinsbergh VW and Koolwijk P: Endothelial sprouting and angiogenesis: Matrix metalloproteinases in the lead. Cardiovasc Res. 78:203–212. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Montuori N and Ragno P: Role of uPA/uPAR in the modulation of angiogenesis. Chem Immunol Allergy. 99:105–122. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kumari S and Malla R: New Insight on the role of plasminogen receptor in cancer progression. Cancer Growth Metastasis. 8:35–42. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P and Waisman DM: Regulation of fibrinolysis by S100A10 in vivo. Blood. 118:3172–3181. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W and Hajjar KA: The annexin A2 system and angiogenesis. Biol Chem. 397:1005–1016. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Valapala M, Thamake SI and Vishwanatha JK: A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. J Cell Sci. 124:1453–1464. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Vempati P, Mac Gabhann F and Popel AS: Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model. PLoS One. 5:e118602010. View Article : Google Scholar : PubMed/NCBI | |
|
Myrvang HK, Guo X, Li C and Dekker LV: Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells. FEBS Lett. 587:3210–3215. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
López-Soto A, Gonzalez S, Smyth MJ and Galluzzi L: Control of Metastasis by NK Cells. Cancer Cell. 32:135–154. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Surette A and Waisman D: S100A10: A Key Regulator of Fibrinolysis. Fibrinolysis Thrombolysis. 2014. View Article : Google Scholar | |
|
Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hitchcock JK, Katz AA and Schäfer G: Dynamic reciprocity: The role of annexin A2 in tissue integrity. J Cell Commun Signal. 8:125–133. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Madureira PA, Bharadwaj AG, Bydoun M, Garant K, O'Connell P, Lee P and Waisman DM: Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget. 7:47720–47737. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Katono K, Sato Y, Jiang SX, Kobayashi M, Saito K, Nagashio R, Ryuge S, Satoh Y, Saegusa M and Masuda N: Clinicopathological significance of S100A10 expression in lung adenocarcinomas. Asian Pac J Cancer Prev. 17:289–294. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ito Y, Arai K, Nozawa R, Yoshida H, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Kuma K and Miyauchi A: S100A10 expression in thyroid neoplasms originating from the follicular epithelium: Contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer Res. 27:2679–2683. 2007.PubMed/NCBI | |
|
Zhang J, Guo B, Zhang Y, Cao J and Chen T: Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc and plasmin and inhibits breast cancer cell proliferation and invasion. Saudi Med J. 31:374–381. 2010.PubMed/NCBI | |
|
Lokman NA, Pyragius CE, Ruszkiewicz A, Oehler MK and Ricciardelli C: Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Transl Res. 171:83–95.e2. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
O'Connell PA and Waisman DM: Regulation of plasmin generation by the annexin A2 heterotetramer: A shift in perspective. Future Oncol. 8:763–765. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Popescu NC and Zimonjic DB: DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. Cancer Res. 71:2916–2925. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K and Tachibana M: Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer. 101:287–294. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Domoto T, Miyama Y, Suzuki H, Teratani T, Arai K, Sugiyama T, Takayama T, Mugiya S, Ozono S and Nozawa R: Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci. 98:77–82. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yamamoto N, Nakamura Y, Morinaga S, Numata K, Sawazaki S, Watanabe T, Numata M, Tamagawa H, Godai T, Shiozawa M, et al: The clinical significance of S100A10 in pancreatic cancer. J Clin Oncol. 31:1942013. View Article : Google Scholar | |
|
Liu J, Li X, Dong GL, Zhang HW, Chen DL, Du JJ, Zheng JY, Li JP and Wang WZ: In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer. 8:2612008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Zhu M, Cheng W, Xing R, Li W, Zhao M, Xu L, Li E, Luo G and Lu Y: Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer. J Cancer Res Clin Oncol. 141:691–703. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Foley K, Muth S, Jaffee E and Zheng L: Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2. Cell Adhes Migr. 11:514–523. 2017. View Article : Google Scholar | |
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G and Thompson CB: The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jones RG and Thompson CB: Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes Dev. 23:537–548. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Labak CM, Wang PY, Arora R, Guda MR, Asuthkar S, Tsung AJ and Velpula KK: Glucose transport: Meeting the metabolic demands of cancer and applications in glioblastoma treatment. Am J Cancer Res. 6:1599–1608. 2016.PubMed/NCBI | |
|
Barron CC, Bilan PJ, Tsakiridis T and Tsiani E: Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Metabolism. 65:124–139. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Masoud GN and Li W: HIF-1α pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sertel S, Eichhorn T, Simon CH, Plinkert PK, Johnson SW and Efferth T: Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines. Molecules. 15:2886–2910. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Miller DM, Thomas SD, Islam A, Muench D and Sedoris K: c-Myc and cancer metabolism. Clin Cancer Res. 18:5546–5553. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Leśniak W: Epigenetic regulation of S100 protein expression. Clin Epigenetics. 2:77–83. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, Isas JM, Langen R and Kast WM: The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One. 7:e435192012. View Article : Google Scholar : PubMed/NCBI | |
|
Dziduszko A and Ozbun MA: Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol. 87:7502–7515. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Woodham AW, Taylor JR, Jimenez AI, Skeate JG, Schmidt T, Brand HE, Da Silva DM and Kast WM: Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection. J Antimicrob Chemother. 70:1686–1690. 2015.PubMed/NCBI | |
|
Litwin TR, Clarke MA, Dean M and Wentzensen N: Somatic host cell alterations in HPV carcinogenesis. Viruses. 9:2062017. View Article : Google Scholar | |
|
Stiasny A, Freier CP, Kuhn C, Schulze S, Mayr D, Alexiou C, Janko C, Wiest I, Dannecker C, Jeschke U and Kost BP: The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer. Oncol Lett. 14:4467–4476. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Genova C, Rijavec E and Grossi F: Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: Can we use enemy territory at our advantage? J Thorac Dis. 9:4300–4304. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tan Y, Ma SY, Wang FQ, Meng HP, Mei C, Liu A and Wu HR: Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer. Oncol Rep. 26:853–859. 2011.PubMed/NCBI |
